DK0674510T3
(da)
*
|
1992-11-27 |
1999-05-10 |
Napro Biotherapeutics Inc |
Injicerbart præparat omfattende paclitaxel
|
TW406020B
(en)
*
|
1993-09-29 |
2000-09-21 |
Bristol Myers Squibb Co |
Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
|
FR2710534B1
(fr)
*
|
1994-09-28 |
1996-07-05 |
Bristol Myers Squibb Co |
Solvant de stabilisation, composition pharmaceutique le contenant, et son procédé de préparation.
|
NL9500340A
(nl)
*
|
1995-02-22 |
1996-10-01 |
Yew Tree Pharmaceuticals B V |
Gestabiliseerde paclitaxel-oplossing en farmaceutisch preparaat dat deze oplossing bevat.
|
DE19536165A1
(de)
*
|
1995-09-28 |
1997-04-03 |
Basf Ag |
Verfahren zur Reinigung von alkoxylierten Fetten
|
US6964946B1
(en)
|
1995-10-26 |
2005-11-15 |
Baker Norton Pharmaceuticals, Inc. |
Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
|
US6395770B1
(en)
*
|
1995-10-26 |
2002-05-28 |
Baker Norton Pharmaceuticals, Inc. |
Method and compositions for administering taxanes orally to human patients
|
US6245805B1
(en)
|
1995-10-26 |
2001-06-12 |
Baker Norton Pharmaceuticals, Inc. |
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
|
AU724842B2
(en)
*
|
1995-12-21 |
2000-09-28 |
Genelabs Technologies, Inc. |
Taxane composition and method
|
US20030157187A1
(en)
*
|
1996-12-02 |
2003-08-21 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing inflammatory diseases
|
US6515016B2
(en)
|
1996-12-02 |
2003-02-04 |
Angiotech Pharmaceuticals, Inc. |
Composition and methods of paclitaxel for treating psoriasis
|
US6495579B1
(en)
|
1996-12-02 |
2002-12-17 |
Angiotech Pharmaceuticals, Inc. |
Method for treating multiple sclerosis
|
EP0954283B1
(en)
|
1996-12-30 |
2007-03-21 |
Battelle Memorial Institute |
Use of a non-encapsulated anticancer drug for the preparation of a formulation for treating neoplasms by inhalation
|
US6727280B2
(en)
*
|
1997-01-07 |
2004-04-27 |
Sonus Pharmaceuticals, Inc. |
Method for treating colorectal carcinoma using a taxane/tocopherol formulation
|
US20030105156A1
(en)
*
|
1997-01-07 |
2003-06-05 |
Nagesh Palepu |
Method for administration of a taxane/tocopherol formulation to enhance taxane therapeutic utility
|
US20030087954A1
(en)
*
|
1997-01-07 |
2003-05-08 |
Sonus Pharmaceuticals, Inc. |
Method of treating bladder carcinoma using a Taxane/Tocopherol formulation
|
US6458373B1
(en)
*
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
BE1011216A3
(fr)
*
|
1997-06-13 |
1999-06-01 |
Thissen En Abrege L T B Lab |
Forme pharmaceutique pour l'administration de paclitaxel, procede de preparation d'une composition de paclitaxel prete a l'emploi et utilisation de cette composition.
|
IL131217A0
(en)
*
|
1998-03-10 |
2001-01-28 |
Napro Biotherapeutics Inc |
Novel methods and compositions for delivery of taxanes
|
US5922754A
(en)
*
|
1998-10-02 |
1999-07-13 |
Abbott Laboratories |
Pharmaceutical compositions containing paclitaxel
|
DE19983660T1
(de)
|
1998-10-20 |
2001-09-13 |
Ben Venue Lab Inc |
Verfahren zur Aufreinigung von Lösungsmitteln, die bei der Herstellung von pharmazeutischen Zusammensetzungen nützlich sind
|
US6071952A
(en)
*
|
1998-12-02 |
2000-06-06 |
Mylan Pharmaceuticals, Inc. |
Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
|
US6040330A
(en)
*
|
1999-01-08 |
2000-03-21 |
Bionumerik Pharmaceuticals, Inc. |
Pharmaceutical formulations of taxanes
|
US6410255B1
(en)
*
|
1999-05-05 |
2002-06-25 |
Aurora Biosciences Corporation |
Optical probes and assays
|
DE60036101T2
(de)
|
1999-05-14 |
2008-05-15 |
Nereus Pharmaceuticals, Inc., San Diego |
Interleukin-1 und tumornekrosefaktor-alpha modulatoren,synthese dieser modulatoren und methoden zur anwendung dieser modulatoren
|
DE19925211B4
(de)
*
|
1999-06-01 |
2006-01-12 |
PBS Pharmaceutical Bulk Substances SA |
Kit zur Herstellung einer Formulierung von Paclitaxel
|
AU776993B2
(en)
*
|
2000-01-20 |
2004-09-30 |
Baker Norton Pharmaceuticals, Inc. |
Purifying polyoxyethylated castor oils with activated charcoal and pharmaceutical formulations thereof
|
MXPA01009900A
(es)
*
|
2000-02-02 |
2003-08-20 |
Univ Florida State Res Found |
Formulaciones de taxano que tienen solubilidad mejorada.
|
CA2400642A1
(en)
*
|
2000-02-23 |
2001-08-30 |
Vertex Pharmaceuticals (San Diego) Llc |
Modified fluorescent proteins
|
JP4922507B2
(ja)
*
|
2000-08-10 |
2012-04-25 |
武田薬品工業株式会社 |
医薬組成物
|
CA2418224C
(en)
|
2000-08-10 |
2010-02-09 |
Takeda Chemical Industries, Ltd. |
Pharmaceutical composition
|
WO2002047610A2
(en)
*
|
2000-11-16 |
2002-06-20 |
The Regents Of The University Of California |
Marine actinomycete taxon for drug and fermentation product dicovery
|
JP2004536026A
(ja)
*
|
2000-11-28 |
2004-12-02 |
トランスフォーム ファーマシューティカルズ,インコーポレーティッド. |
パクリタキセル、その誘導体、および薬剤として許容される塩を含む医薬品製剤
|
US7141251B2
(en)
|
2001-04-06 |
2006-11-28 |
Cytorex Biosciences, Inc. |
Pharmacologically active strong acid solutions
|
KR100774366B1
(ko)
*
|
2001-09-10 |
2007-11-08 |
주식회사 중외제약 |
파클리탁셀 주사제 조성물
|
JP2005515187A
(ja)
*
|
2001-11-26 |
2005-05-26 |
スーパージェン インコーポレイテッド |
ポリオキシエチル化ひまし油を使用する医薬組成物の調製方法
|
US20040092428A1
(en)
*
|
2001-11-27 |
2004-05-13 |
Hongming Chen |
Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
|
US6476068B1
(en)
*
|
2001-12-06 |
2002-11-05 |
Pharmacia Italia, S.P.A. |
Platinum derivative pharmaceutical formulations
|
BR0215184A
(pt)
*
|
2001-12-20 |
2006-06-06 |
Bristol Myers Squibb Co |
composições farmacêuticas de derivados de taxano oralmente ativos tendo biodisponibilidade aumentada
|
CZ294371B6
(cs)
*
|
2002-06-10 |
2004-12-15 |
Pliva - Lachema, A. S. |
Stabilizovaná farmaceutická kompozice na bázi polyoxyethylovaného ricinového oleje a způsob její přípravy
|
US7176232B2
(en)
|
2002-06-24 |
2007-02-13 |
The Regents Of The University Of California |
Salinosporamides and methods for use thereof
|
DE60329497D1
(de)
|
2002-06-26 |
2009-11-12 |
Medigene Ag |
Herstellung einer kationisch liposomalen zubereitung, einen lipophilen wirkstoff enthaltend
|
US7935704B2
(en)
*
|
2003-08-01 |
2011-05-03 |
Nereus Pharmaceuticals, Inc. |
Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
|
US7919497B2
(en)
*
|
2002-08-02 |
2011-04-05 |
Nereus Pharmaceuticals, Inc. |
Analogs of dehydrophenylahistins and their therapeutic use
|
IL166628A0
(en)
*
|
2002-08-02 |
2006-01-15 |
Nereus Pharmaceuticals Inc |
Dehydrophenyl lahistins and analogs thereof and the synthesis of dehydrophenyllahistins and analogs thereof
|
AU2003296908A1
(en)
*
|
2002-09-27 |
2004-05-04 |
Nereus Pharmaceuticals, Inc. |
Macrocyclic lactams
|
US20040122081A1
(en)
*
|
2002-11-08 |
2004-06-24 |
Gogate Uday Shankar |
Pharmaceutical compositions and methods of using taxane derivatives
|
WO2004072104A2
(en)
*
|
2003-02-11 |
2004-08-26 |
Northwestern University |
Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon
|
DE602004031614D1
(de)
*
|
2003-06-20 |
2011-04-14 |
Nereus Pharmaceuticals Inc |
Verwendung von (3.2.0) heterocyclischen verbindungen und ihren analoga zur behandlung von krebs
|
ZA200600473B
(en)
*
|
2003-06-20 |
2007-04-25 |
Univ California |
Salinosporamides and methods for use thereof
|
US20050016926A1
(en)
*
|
2003-07-24 |
2005-01-27 |
Dabur Research Foundation |
Stabilized formulation
|
US7619059B2
(en)
*
|
2003-07-29 |
2009-11-17 |
Life Technologies Corporation |
Bimolecular optical probes
|
US7727752B2
(en)
*
|
2003-07-29 |
2010-06-01 |
Life Technologies Corporation |
Kinase and phosphatase assays
|
CA2445420A1
(en)
*
|
2003-07-29 |
2005-01-29 |
Invitrogen Corporation |
Kinase and phosphatase assays
|
US20050208095A1
(en)
*
|
2003-11-20 |
2005-09-22 |
Angiotech International Ag |
Polymer compositions and methods for their use
|
ES2325506T3
(es)
*
|
2003-12-12 |
2009-09-07 |
Quiral Quimica Do Brasil |
Procedimiento para la preparacion de principios activos farmaceuticos (api) anhidros e hidratados; composiciones farmaceuticas estables preparadas a partir de los mismos y usos de dichas composiciones.
|
KR20060132698A
(ko)
*
|
2004-01-23 |
2006-12-21 |
니리어스 파마슈티컬즈, 인코퍼레이션 |
항균제로 유용한 비스-인돌 피롤
|
KR20050099311A
(ko)
*
|
2004-04-09 |
2005-10-13 |
에이엔에이치 케어연구소(주) |
주사제용 항암제 조성물
|
BRPI0509824A
(pt)
*
|
2004-04-30 |
2007-10-09 |
Nereus Pharmaceuticals Inc |
compostos heterocìclicos [3.2.0] e métodos de uso dos mesmos
|
US7579371B2
(en)
|
2004-04-30 |
2009-08-25 |
Nereus Pharmaceuticals, Inc. |
Methods of using [3.2.0] heterocyclic compounds and analogs thereof
|
US7361683B2
(en)
*
|
2004-11-24 |
2008-04-22 |
Yung Shin Pharm. Ind., Co., Ltd |
Paclitaxel aqueous injection solution and methods for preparing the same
|
CN103230394B
(zh)
*
|
2004-12-03 |
2016-04-20 |
达纳-法伯癌症研究公司 |
治疗肿瘤性疾病的化合物及其用途
|
KR20060121721A
(ko)
*
|
2005-05-23 |
2006-11-29 |
주식회사 중외제약 |
테트라플루오로벤질 유도체 또는 그의 염을 함유하는주사제용 조성물
|
EP2138164A1
(en)
*
|
2005-06-17 |
2009-12-30 |
Hospira Australia Pty Ltd |
Liquid pharmaceutical formulations of docetaxel
|
EP1912932B1
(en)
|
2005-07-21 |
2012-05-02 |
Nereus Pharmaceuticals, Inc. |
Interleukin-1 and tumor necrosis factor-a modulators; syntheses of such modulators and methods of using such modulators
|
TR200801336T1
(tr)
|
2005-08-31 |
2008-08-21 |
Abraxis Bioscience, Inc. |
Kararlılığı artmış zayıf su çöznurluğune sahip ilaçların preparasyonuna yönelik kompozisyonlar ve yöntemler.
|
ES2719093T3
(es)
|
2005-08-31 |
2019-07-08 |
Abraxis Bioscience Llc |
Composiciones de fármacos poco solubles en agua con mayor estabilidad y métodos para su preparación
|
BRPI0600194A
(pt)
*
|
2006-01-30 |
2007-10-23 |
Quiral Quimica Do Brasil S A |
composições farmacêuticas contendo docetaxel e um inibidor de degradação e processo de obtenção das mesmas
|
US8129527B2
(en)
*
|
2006-11-03 |
2012-03-06 |
Nereus Pharmacuticals, Inc. |
Analogs of dehydrophenylahistins and their therapeutic use
|
WO2008095195A2
(en)
*
|
2007-02-02 |
2008-08-07 |
Nereus Pharmaceuticals, Inc. |
Lyophilized formulations of salinosporamide a
|
FR2912745A1
(fr)
*
|
2007-02-19 |
2008-08-22 |
Centre Nat Rech Scient |
Nouveaux composes derives d'indole et compositions pharmaceutiques les contenant
|
US20090017167A1
(en)
*
|
2007-07-11 |
2009-01-15 |
Herbalife International Inc. |
Mixture and beverage made therefrom for protecting cellular hydration
|
US8394816B2
(en)
*
|
2007-12-07 |
2013-03-12 |
Irene Ghobrial |
Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's Macroglobulinemia
|
KR101053780B1
(ko)
*
|
2008-02-29 |
2011-08-02 |
동아제약주식회사 |
도세탁셀을 함유하는 단일액상의 안정한 약제학적 조성물
|
EP2276765A4
(en)
*
|
2008-05-12 |
2011-10-19 |
Nereus Pharmaceuticals Inc |
SALINOSPORAMIDE DERIVATIVES AS PROTEASOMAL HEMMER
|
ES2344674B1
(es)
|
2008-08-07 |
2011-06-29 |
Gp Pharm, S.A. |
Composicion farmaceutica inyectable de taxanos.
|
US8257722B2
(en)
|
2008-09-15 |
2012-09-04 |
Cv Ingenuity Corp. |
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
|
US9198968B2
(en)
|
2008-09-15 |
2015-12-01 |
The Spectranetics Corporation |
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
|
US8114429B2
(en)
|
2008-09-15 |
2012-02-14 |
Cv Ingenuity Corp. |
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
|
US8128951B2
(en)
|
2008-09-15 |
2012-03-06 |
Cv Ingenuity Corp. |
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
|
TWI438009B
(zh)
*
|
2010-02-19 |
2014-05-21 |
Teikoku Pharma Usa Inc |
紫杉烷前-乳劑調配物及其製造與使用之方法
|
BR112012028037A2
(pt)
|
2010-05-03 |
2016-08-02 |
Teikoku Pharma Usa Inc |
formulação de pró-emulsão líquida de taxano não aquosa, métodos para administrar um taxano a um paciente e para fabricar uma formulação de pró-emulsão de taxano, composição de emulsão de taxano, e, kit
|
EA025572B1
(ru)
|
2011-03-29 |
2017-01-30 |
Санофи |
Лекарственные формы отамиксабана с улучшенной стабильностью
|
EP2731938A4
(en)
*
|
2011-07-11 |
2014-12-24 |
Biolyse Pharma Corp |
NOVEL ISOCARBOSTYRIL-ALKALOID CONJUGATES OF ANTI-CANCER
|
US9956385B2
(en)
|
2012-06-28 |
2018-05-01 |
The Spectranetics Corporation |
Post-processing of a medical device to control morphology and mechanical properties
|
JO3685B1
(ar)
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
|
EP2777691A1
(en)
|
2013-03-14 |
2014-09-17 |
Pharmachemie B.V. |
Taxoid - Purification of Liquid Excipients
|
WO2014152562A1
(en)
*
|
2013-03-15 |
2014-09-25 |
Epizyme, Inc. |
Injectable formulations for treating cancer
|
US10525171B2
(en)
|
2014-01-24 |
2020-01-07 |
The Spectranetics Corporation |
Coatings for medical devices
|
JP2017527614A
(ja)
|
2014-09-02 |
2017-09-21 |
ブピンダー シン |
重水素化又は非重水素化分子及び医薬製剤
|
JP2017527567A
(ja)
*
|
2014-09-17 |
2017-09-21 |
エピザイム インコーポレイテッド |
癌の治療のための注射製剤
|
US10751317B2
(en)
|
2014-10-08 |
2020-08-25 |
Pacific Northwest Research Institute |
Methods and compositions for increasing the potency of antifungal agents
|
US10076518B2
(en)
|
2015-03-06 |
2018-09-18 |
Beyondspring Pharmaceuticals, Inc. |
Method of treating a brain tumor
|
US10238650B2
(en)
|
2015-03-06 |
2019-03-26 |
Beyondspring Pharmaceuticals, Inc. |
Method of treating cancer associated with a RAS mutation
|
MX2018000451A
(es)
|
2015-07-13 |
2018-05-07 |
Beyondspring Pharmaceuticals Inc |
Composiciones de plinabulina.
|
US10561766B2
(en)
*
|
2015-09-15 |
2020-02-18 |
W. L. Gore & Associates, Inc. |
Drug composition and coating
|
RU2753543C1
(ru)
|
2016-02-08 |
2021-08-17 |
Бейондспринг Фармасьютикалс, Инк. |
Композиции, содержащие тукаресол или его аналоги
|
WO2017214052A1
(en)
|
2016-06-06 |
2017-12-14 |
Beyondspring Pharmaceuticals, Inc. |
Composition and method for reducing neutropenia
|
WO2018129381A1
(en)
|
2017-01-06 |
2018-07-12 |
Beyondspring Pharmaceuticals, Inc. |
Tubulin binding compounds and therapeutic use thereof
|
JP2020514412A
(ja)
|
2017-02-01 |
2020-05-21 |
ビヨンドスプリング ファーマシューティカルズ,インコーポレイテッド |
好中球減少症の低減方法
|
US10226423B1
(en)
*
|
2017-12-20 |
2019-03-12 |
RxOMEG Therapeutics LLC |
Colchicine drug-to-drug interactions
|
KR20200112881A
(ko)
|
2018-01-24 |
2020-10-05 |
비욘드스프링 파마수티컬스, 인코포레이티드. |
플리나불린의 투여를 통해 혈소판감소증을 감소시키는 조성물 및 방법
|
WO2019191119A1
(en)
|
2018-03-28 |
2019-10-03 |
Herbalife International Of America, Inc. |
Acetylation of polysaccharides
|
BR112021005104A2
(pt)
*
|
2018-10-16 |
2021-06-08 |
US Nano Food & Drug INC |
formulação de injeção intratumoral
|
WO2021211294A1
(en)
|
2020-04-13 |
2021-10-21 |
US Nano Food & Drug INC |
Basic chemotherapeutic intratumour injection formulation
|